Management of Severe Metabolic Acidosis with Impaired Renal Function

Clinical Context and Severity Assessment

A bicarbonate level of 8 mmol/L represents severe, life-threatening metabolic acidosis, far below the 18 mmol/L threshold where pharmacological treatment is strongly recommended, particularly in patients with impaired renal acid excretion due to advanced chronic kidney disease, as indicated by a serum creatinine of 258 μmol/L 1
Advanced CKD impairs the kidney's ability to excrete hydrogen ions and synthesize ammonia, leading to progressive acid accumulation, and requires vigorous bicarbonate therapy to correct severe renal impairment 1

The National Kidney Foundation guidelines recommend maintaining serum bicarbonate at or above 22 mmol/L to prevent protein catabolism, bone disease, and CKD progression, and once bicarbonate reaches 18-20 mmol/L, transition to oral sodium bicarbonate 0.5-1.0 mEq/kg/day divided into 2-3 doses to maintain bicarbonate ≥22 mmol/L 1, 2
Monitor serum bicarbonate monthly initially, then every 3-4 months once stable, and check blood pressure, serum potassium, and fluid status regularly, as oral sodium bicarbonate can cause hypertension or volume overload in susceptible patients 1

Do NOT use sodium bicarbonate to treat metabolic acidosis arising from tissue hypoperfusion in septic shock—focus on restoring perfusion first, and avoid using bicarbonate in diabetic ketoacidosis unless pH falls below 6.9-7.0, as insulin and fluid resuscitation correct the underlying ketoacidosis 1, 3
Avoid citrate-containing alkali preparations in CKD patients exposed to aluminum-containing phosphate binders, as citrate increases aluminum absorption 1

Severe metabolic acidosis causes increased protein catabolism and muscle wasting, bone demineralization, decreased cardiac output, predisposition to arrhythmias, and accelerated CKD progression 1